Filing Details
- Accession Number:
- 0000911916-17-000028
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-01-04 16:25:34
- Reporting Period:
- 2017-01-03
- Filing Date:
- 2017-01-04
- Accepted Time:
- 2017-01-04 16:25:34
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1348649 | Colucid Pharmaceuticals Inc. | CLCD | Pharmaceutical Preparations (2834) | 203419541 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1639976 | Bernice Kuca | C/O Colucid Pharmaceuticals, Inc. 222 Third Street Cambridge MA 02142 | Head,Clin. And Reg. Operations | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2017-01-03 | 772 | $36.25 | 40,086 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Footnotes
- Securities sold pursuant to a written plan intended to comply with Rule 10b5-1(c)(i) adopted by Ms. Kuca on August 15, 2016. One purpose of the plan is to sell shares of common stock acquired under the CoLucid Pharmaceuticals, Inc. Employee Stock Purchase Plan.